Common inflammatory markers predict risk of ABPA development in children with cystic fibrosis
Journal of Cystic Fibrosis · 2026
DOI: 10.1016/j.jcf.2026.01.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2026. Verfasst von Harriet E D Crabtree und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Sleep Medicine, Perth Children's Hospital, Perth, Australia. Hauptthemen laut MEDLINE: Cystic Fibrosis, Aspergillosis, Allergic Bronchopulmonary, Immunoglobulin E. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Medical Research Future Fund, Western Australian Future Health and Innovation Fund, Government of Western Australia.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) contributes to progressive lung damage in people with cystic fibrosis (pwCF), particularly when diagnosis is delayed. Early diagnosis remains challenging due to insidious onset and non-specific symptoms. We aimed to assess the utility of routinely collected biomarkers in predicting ABPA in children with CF. METHODS: A retrospective analysis of pwCF aged 0-18 years in Western Australia from 2000 to 2020. Longitudinal levels of total IgE, eosinophils (Eo), and Aspergillus-specific IgE (Asp-sp IgE) preceding ABPA diagnosis were compared with age- and sex-matched controls. RESULTS: Among 346 children with CF, 19 (5.4%) were diagnosed with ABPA. Distinct elevations in Asp-sp IgE, total IgE, and Eo were observed up to five years before clinical diagnosis. Total IgE almost doubled and Asp-sp IgE nearly tripled in the three years preceding diagnosis. Persistent normal values across all three markers were strongly associated with low risk of ABPA. Children with total IgE levels
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Sleep Medicine, Perth Children's Hospital, Perth, Australia.
- Wal-yan Respiratory Research Centre, The Kids Research Institute Australia, Perth, Australia; UWA Centre for Child Health Research, The University of Western Australia, Perth, Australia.
- Wal-yan Respiratory Research Centre, The Kids Research Institute Australia, Perth, Australia.
- Department of Infectious Diseases, Perth Children's Hospital, Perth, Australia.
- Department of Infectious Diseases, Perth Children's Hospital, Perth, Australia; Wesfarmers Centre for Vaccines and Infectious Diseases, The Kids Research Institute Australia, The University of Western Australia, Perth,…
- Department of Respiratory and Sleep Medicine, Perth Children's Hospital, Perth, Australia; Wal-yan Respiratory Research Centre, The Kids Research Institute Australia, Perth, Australia.
Förderung
- Medical Research Future Fund
- Western Australian Future Health and Innovation Fund, Government of Western Australia
Zitieren
APA
Crabtree, H. E. D., Malajczuk, C. J., Ho, H. Y., Edmiston, P. M., Yeoh, D. K., Wilson, A. C., Karpievitch, Y. V., & Schultz, A. (2026). Common inflammatory markers predict risk of ABPA development in children with cystic fibrosis. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2026.01.005
Vancouver
Crabtree HED, Malajczuk CJ, Ho HY, Edmiston PM, Yeoh DK, Wilson AC, et al. Common inflammatory markers predict risk of ABPA development in children with cystic fibrosis. Journal of Cystic Fibrosis. 2026. doi:10.1016/j.jcf.2026.01.005
BibTeX
@article{Crabtree2026,
author = {Crabtree, Harriet E D and Malajczuk, Chris J and Ho, Ho Yin and Edmiston, Phillipa M and Yeoh, Daniel K and Wilson, Andrew C and Karpievitch, Yuliya V and Schultz, André},
title = {Common inflammatory markers predict risk of ABPA development in children with cystic fibrosis},
journal = {Journal of Cystic Fibrosis},
year = {2026},
doi = {10.1016/j.jcf.2026.01.005}
}
EUVIMED